Logo image of CTRI

CENTURI HOLDINGS INC (CTRI) Stock Fundamental Analysis

NYSE:CTRI - New York Stock Exchange, Inc. - US1559231055 - Common Stock - Currency: USD

20.7  +0.49 (+2.42%)

After market: 20.7 0 (0%)

Fundamental Rating

3

CTRI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 49 industry peers in the Construction & Engineering industry. The financial health of CTRI is average, but there are quite some concerns on its profitability. CTRI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CTRI had positive earnings in the past year.
CTRI had a positive operating cash flow in the past year.
CTRI Yearly Net Income VS EBIT VS OCF VS FCFCTRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.15%, CTRI is doing worse than 65.31% of the companies in the same industry.
CTRI has a worse Return On Equity (-0.57%) than 65.31% of its industry peers.
CTRI has a Return On Invested Capital of 4.34%. This is comparable to the rest of the industry: CTRI outperforms 46.94% of its industry peers.
CTRI had an Average Return On Invested Capital over the past 3 years of 4.36%. This is significantly below the industry average of 16.87%.
Industry RankSector Rank
ROA -0.15%
ROE -0.57%
ROIC 4.34%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
CTRI Yearly ROA, ROE, ROICCTRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

CTRI has a Operating Margin (3.50%) which is comparable to the rest of the industry.
CTRI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 8.67%, CTRI is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
CTRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 8.67%
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
CTRI Yearly Profit, Operating, Gross MarginsCTRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 -5

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CTRI is destroying value.
Compared to 1 year ago, CTRI has more shares outstanding
The debt/assets ratio for CTRI has been reduced compared to a year ago.
CTRI Yearly Shares OutstandingCTRI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
CTRI Yearly Total Debt VS Total AssetsCTRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.18 indicates that CTRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRI has a Altman-Z score of 2.18. This is comparable to the rest of the industry: CTRI outperforms 46.94% of its industry peers.
The Debt to FCF ratio of CTRI is 7.09, which is on the high side as it means it would take CTRI, 7.09 years of fcf income to pay off all of its debts.
CTRI's Debt to FCF ratio of 7.09 is in line compared to the rest of the industry. CTRI outperforms 53.06% of its industry peers.
CTRI has a Debt/Equity ratio of 1.59. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.59, CTRI is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 7.09
Altman-Z 2.18
ROIC/WACC0.39
WACC11.08%
CTRI Yearly LT Debt VS Equity VS FCFCTRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.72 indicates that CTRI should not have too much problems paying its short term obligations.
CTRI has a better Current ratio (1.72) than 81.63% of its industry peers.
CTRI has a Quick Ratio of 1.72. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a better Quick ratio (1.72) than 89.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.72
Quick Ratio 1.72
CTRI Yearly Current Assets VS Current LiabilitesCTRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 96.24% over the past year.
CTRI shows a decrease in Revenue. In the last year, the revenue decreased by -9.04%.
CTRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.90% yearly.
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5%
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%7.73%

3.2 Future

CTRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.73% yearly.
Based on estimates for the next years, CTRI will show a small growth in Revenue. The Revenue will grow by 5.50% on average per year.
EPS Next Y127.79%
EPS Next 2Y77.96%
EPS Next 3Y62.73%
EPS Next 5YN/A
Revenue Next Year5.55%
Revenue Next 2Y5.48%
Revenue Next 3Y5.5%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CTRI Yearly Revenue VS EstimatesCTRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CTRI Yearly EPS VS EstimatesCTRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 60.88, which means the current valuation is very expensive for CTRI.
61.22% of the companies in the same industry are cheaper than CTRI, based on the Price/Earnings ratio.
CTRI is valuated expensively when we compare the Price/Earnings ratio to 26.73, which is the current average of the S&P500 Index.
CTRI is valuated rather expensively with a Price/Forward Earnings ratio of 22.54.
CTRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CTRI is cheaper than 65.31% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.61, CTRI is valued a bit cheaper.
Industry RankSector Rank
PE 60.88
Fwd PE 22.54
CTRI Price Earnings VS Forward Price EarningsCTRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

CTRI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTRI is cheaper than 81.63% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CTRI is valued cheaply inside the industry as 87.76% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.87
EV/EBITDA 10.35
CTRI Per share dataCTRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CTRI's earnings are expected to grow with 62.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.48
PEG (5Y)N/A
EPS Next 2Y77.96%
EPS Next 3Y62.73%

0

5. Dividend

5.1 Amount

No dividends for CTRI!.
Industry RankSector Rank
Dividend Yield N/A

CENTURI HOLDINGS INC

NYSE:CTRI (8/12/2025, 8:04:01 PM)

After market: 20.7 0 (0%)

20.7

+0.49 (+2.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners30.14%
Inst Owner Change1.05%
Ins Owners0.35%
Ins Owner Change-54.63%
Market Cap1.84B
Analysts75.38
Price Target23.15 (11.84%)
Short Float %3.83%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.02%
Min EPS beat(2)-22.01%
Max EPS beat(2)19.97%
EPS beat(4)1
Avg EPS beat(4)-21.69%
Min EPS beat(4)-80.47%
Max EPS beat(4)19.97%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.31%
Min Revenue beat(2)-0.09%
Max Revenue beat(2)0.7%
Revenue beat(4)2
Avg Revenue beat(4)-0.52%
Min Revenue beat(4)-7.13%
Max Revenue beat(4)4.44%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.71%
PT rev (3m)8.61%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.72%
EPS NY rev (1m)0%
EPS NY rev (3m)5.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.93%
Valuation
Industry RankSector Rank
PE 60.88
Fwd PE 22.54
P/S 0.68
P/FCF 13.87
P/OCF 8.2
P/B 3.24
P/tB N/A
EV/EBITDA 10.35
EPS(TTM)0.34
EY1.64%
EPS(NY)0.92
Fwd EY4.44%
FCF(TTM)1.49
FCFY7.21%
OCF(TTM)2.52
OCFY12.19%
SpS30.58
BVpS6.4
TBVpS-1.52
PEG (NY)0.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -0.57%
ROCE 5.5%
ROIC 4.34%
ROICexc 4.42%
ROICexgc 7.52%
OM 3.5%
PM (TTM) N/A
GM 8.67%
FCFM 4.88%
ROA(3y)-5.23%
ROA(5y)N/A
ROE(3y)-42.36%
ROE(5y)N/A
ROIC(3y)4.36%
ROIC(5y)N/A
ROICexc(3y)4.47%
ROICexc(5y)N/A
ROICexgc(3y)8.1%
ROICexgc(5y)N/A
ROCE(3y)5.52%
ROCE(5y)N/A
ROICexcg growth 3Y-0.39%
ROICexcg growth 5YN/A
ROICexc growth 3Y9.2%
ROICexc growth 5YN/A
OM growth 3Y-6.01%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.56%
GM growth 5YN/A
F-Score5
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF 7.09
Debt/EBITDA 3.46
Cap/Depr 55.05%
Cap/Sales 3.37%
Interest Coverage 250
Cash Conversion 85.71%
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z 2.18
F-Score5
WACC11.08%
ROIC/WACC0.39
Cap/Depr(3y)68.49%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.05%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5%
EPS Next Y127.79%
EPS Next 2Y77.96%
EPS Next 3Y62.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.04%
Revenue growth 3Y6.9%
Revenue growth 5YN/A
Sales Q2Q%7.73%
Revenue Next Year5.55%
Revenue Next 2Y5.48%
Revenue Next 3Y5.5%
Revenue Next 5YN/A
EBIT growth 1Y-36.39%
EBIT growth 3Y0.48%
EBIT growth 5YN/A
EBIT Next Year149.67%
EBIT Next 3Y44.99%
EBIT Next 5YN/A
FCF growth 1Y-3.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.51%
OCF growth 3Y13.06%
OCF growth 5YN/A